DE69622706T2 - Durchscheinende kollagenformulierungen - Google Patents

Durchscheinende kollagenformulierungen

Info

Publication number
DE69622706T2
DE69622706T2 DE69622706T DE69622706T DE69622706T2 DE 69622706 T2 DE69622706 T2 DE 69622706T2 DE 69622706 T DE69622706 T DE 69622706T DE 69622706 T DE69622706 T DE 69622706T DE 69622706 T2 DE69622706 T2 DE 69622706T2
Authority
DE
Germany
Prior art keywords
compositions
collagen formulations
transparent collagen
cytotoxic drug
translucent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622706T
Other languages
English (en)
Other versions
DE69622706D1 (de
Inventor
E Jones
T Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matrix Pharmaceutical Inc
Original Assignee
Matrix Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharmaceutical Inc filed Critical Matrix Pharmaceutical Inc
Publication of DE69622706D1 publication Critical patent/DE69622706D1/de
Application granted granted Critical
Publication of DE69622706T2 publication Critical patent/DE69622706T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69622706T 1995-04-28 1996-04-26 Durchscheinende kollagenformulierungen Expired - Fee Related DE69622706T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/431,084 US5750146A (en) 1995-04-28 1995-04-28 Translucent collagen formulations with a cytotoxic drug
PCT/US1996/006210 WO1996033696A1 (en) 1995-04-28 1996-04-26 Novel collagen formulations

Publications (2)

Publication Number Publication Date
DE69622706D1 DE69622706D1 (de) 2002-09-05
DE69622706T2 true DE69622706T2 (de) 2003-03-13

Family

ID=23710385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622706T Expired - Fee Related DE69622706T2 (de) 1995-04-28 1996-04-26 Durchscheinende kollagenformulierungen

Country Status (14)

Country Link
US (2) US5750146A (de)
EP (1) EP0825848B1 (de)
JP (1) JPH11504904A (de)
KR (1) KR100437507B1 (de)
CN (1) CN1183039A (de)
AT (1) ATE221370T1 (de)
AU (1) AU719675B2 (de)
CA (1) CA2218037A1 (de)
DE (1) DE69622706T2 (de)
DK (1) DK0825848T3 (de)
ES (1) ES2180776T3 (de)
NZ (1) NZ307791A (de)
PT (1) PT825848E (de)
WO (1) WO1996033696A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6673370B2 (en) * 2001-05-15 2004-01-06 Biomedicines, Inc. Oxidized collagen formulations for use with non-compatible pharmaceutical agents
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8852637B2 (en) * 2008-11-14 2014-10-07 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
EP2640429B1 (de) 2010-11-15 2016-12-21 Zimmer Orthobiologics, Inc. Füller für knochenhohlräume
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US9452240B2 (en) 2013-03-15 2016-09-27 Orthovita, Inc. Pepsinized collagen implants and biomedical uses thereof
EP3675912B1 (de) * 2017-10-12 2024-01-10 SolyPlus GmbH Verfahren zur herstellung von konzentrierten und homogen benetzten massiven polymeren und anwendungen davon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33375A (en) * 1861-10-01 Improvement in pumps
US2589210A (en) * 1945-09-24 1952-03-18 Parke Davis & Co Therapeutic compositions
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
EP0086627B1 (de) * 1982-02-12 1985-08-28 Unitika Ltd. Antikrebsmittel
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
JP2862175B2 (ja) * 1988-02-11 1999-02-24 マトリクス ファーマスーティカル，インコーポレイテッド 細胞障害剤が有する神経障害作用の軽減のための医薬組成物
US5480644A (en) * 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters

Also Published As

Publication number Publication date
ATE221370T1 (de) 2002-08-15
PT825848E (pt) 2002-12-31
EP0825848B1 (de) 2002-07-31
KR19990008143A (ko) 1999-01-25
US5980946A (en) 1999-11-09
DE69622706D1 (de) 2002-09-05
JPH11504904A (ja) 1999-05-11
ES2180776T3 (es) 2003-02-16
KR100437507B1 (ko) 2004-08-16
NZ307791A (en) 1999-04-29
CN1183039A (zh) 1998-05-27
WO1996033696A1 (en) 1996-10-31
US5750146A (en) 1998-05-12
CA2218037A1 (en) 1996-10-31
AU719675B2 (en) 2000-05-18
EP0825848A1 (de) 1998-03-04
DK0825848T3 (da) 2002-11-11
AU5723796A (en) 1996-11-18
EP0825848A4 (de) 1998-08-12

Similar Documents

Publication Publication Date Title
NO964976D0 (no) Kopolymer-1-forbedringer kopolymerpreparater
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
SE8903042L (sv) Pharmaceutical compositions comprising cyklosporins
IT1276723B1 (it) Formulazioni di analoghi dell'insulina
EE9900413A (et) Medikamentide kontrollitud väljutamine silma eeskambrisse
MX9205181A (es) Composiciones mejoradas de hidrogeles polimericos que contienen silicona.
NO974498D0 (no) Monomere insulinanalogformuleringer
NO20010312D0 (no) Optisk element med mikroprismestruktur for avböyning av lysstråler
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
IS4706A (is) Lyfjasamsetningar
DE69622706T2 (de) Durchscheinende kollagenformulierungen
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
DE68908297D1 (de) Formgepresste zusammensetzungen.
ES2170197T3 (es) Composicion detergente.
FI970934A0 (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
DE69608875D1 (de) Härtbare Siliconzusammensetzungen
UA26431A (uk) Похідhі сиh-ізомеру цефалоспориhу, їх оптичhо активhі аhтиподи або рацемічhа суміш, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі
DE69428456T2 (de) Silikon-modifizierte phospholipid-zusammensetzungen
IT1202426B (it) Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
NO942023D0 (no) Stabiliserte polymersammensetninger
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
KR970000198A (ko) 치근 이식물
DE68914047D1 (de) Polymer-Zusammensetzungen.
DE58906999D1 (de) Oxetanylgruppen enthaltende thermoplastische Formmassen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee